Tag Archives: healthcare

So, Where Are We with ACOs?

Tom Norton gets to grips with what an Accountable Care Organization is … and what it is not. Sixteen months into the new Healthcare Reform law, many continue to wonder about the status one of the most confused aspects of the new HCR — the elusive Accountable Care Organization, or ACO. And why are ACOs […]
Posted in Guest Blog, Regulatory | Also tagged , , , , | 2 Comments

Allergan Offers to Pay Journos to Discuss Botox

Physicians aren’t the only ones getting paid to attend industry-sponsored events heavy on product discussions. For $250, “select” journalists can discuss facial aesthetics at an event sponsored by Botox-maker Allergan, on June 9 in New York City. Journalistic ethics can be checked at the door. The emailed invitation to attend Allergan’s Facial Aesthetics Advisory Panel, […]
Posted in Events, Strategy, Uncategorized | Also tagged , , | 1 Comment

Pharma Feels Delayed Effects of Economic Crisis

A new study from the IMS institute for Healthcare Informatics reveals that the spending increase on prescription medication in 2010 was the second-lowest increase in more than half a century. According to the IMS Institute for Healthcare Informatics, spending on prescription medications increased 2.3 percent in 2010 — a lower increase than the 5.1 percent […]
Posted in healthcare | Also tagged , | Leave a comment

Governor Howard Dean: Financing the Future of US Drug Innovation

Will it be More Good Pills — Or that Porsche? The Obama Administration’s signal achievement to date — passage of comprehensive health reform legislation — continues to inspire confusion and contradictions across the political spectrum. Despite its scope, the bill is dismissed by many Democrats for what it does not do, while the GOP references […]
Posted in FDA, healthcare, R&D, Regulatory | Also tagged , , , , | 1 Comment

California Biotech — Good Governance Tops Wish List

New industry survey data documents a fraying investment base marked by a distant and unresponsive FDA as well as an unprepared work force complacent about hungry foreign competition. California’s biotech industry has taken its annual pulse of business conditions — and while the prognosis is not for putting the state on the policy equivalent of […]
Posted in Biotech, FDA, healthcare, R&D, Strategy | Also tagged , , , , | Leave a comment
  • Categories

  • Meta